ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

Clinical trial NCT00823342 · TERMINATED

Trial details

NCT number: NCT00823342
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

HBe Negative Chronic Hepatitis B Hepatitis B Viral Infection

Start date: 2008-12-14
Primary completion: 2008-12-14
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.